Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
2.
Eur J Clin Invest ; 45(11): 1145-52, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26269154

ABSTRACT

BACKGROUND: Cancer of unknown primary (CUP) possesses distinct biology and peculiar natural history, in which the roles of the winged and hedgehog signalling pathways are unclear. MATERIALS AND METHODS: We constructed tissue microarrays and studied the immunohistochemical (IHC) expression of ß-catenin, smoothened (SMO) and the transcription factors TCF, LEF, GLI1 in 87 CUP cases for prognostic significance. RESULTS: A low rate of IHC expression of proteins was seen, the cut-off used being any expression in ≥ 1% of tumour cells. At univariate analysis, only nuclear IHC SMO expression displayed a statistically significant association with favourable outcome [median Overall survival (OS) of 19 months in SMO-positive vs. 12 months in SMO-negative cases, P = 0·01]. An activated Wnt pathway, defined as IHC expression of any of nuclear ß-catenin, TCF and LEF, was significantly associated with favourable progression free survival (median 9 vs. 5 months, P = 0·037) and OS (median 19 vs. 13 months, P = 0·04). This prognostic impact on OS was mainly driven by nuclear expression of TCF and/or LEF (P = 0·03). No prognostic significance of the hedgehog pathway activation status, defined as IHC expression of SMO or nuclear GLI1, could be established. A favourable prognostic impact of the concurrent activation of both pathways was observed. A trend for association of activated Wnt with response to chemotherapy (responders 67% among activated Wnt cases vs. 35% among nonactivated Wnt cases, P = 0·07) was observed in CUP adenocarcinomas. CONCLUSIONS: Activation of the Wnt pathway was a positive prognostic factor in a small CUP series, possibly via enhanced chemosensitivity. Independent validation is warranted.


Subject(s)
Adenocarcinoma/metabolism , Carcinoma, Squamous Cell/metabolism , Hedgehog Proteins , Neoplasms, Unknown Primary/metabolism , Neuroendocrine Tumors/metabolism , Wnt Signaling Pathway , Adenocarcinoma/mortality , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/mortality , Female , Humans , Immunohistochemistry , Lymphoid Enhancer-Binding Factor 1/metabolism , Male , Middle Aged , Neoplasms, Unknown Primary/mortality , Neuroendocrine Tumors/mortality , Prognosis , Receptors, G-Protein-Coupled/metabolism , Retrospective Studies , Smoothened Receptor , TCF Transcription Factors/metabolism , Tissue Array Analysis , Transcription Factors/metabolism , Zinc Finger Protein GLI1 , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...